fbpx
Connect with us

News

Femtech company award finalist for hormone mapping product

Avatar photo

Published

on

Innovative femtech company Forth has been nominated for the ‘Innovation in Health Tech’ award, at the LaingBuisson Awards 2022. 

The CEO of femtech firm Forth previously made the 2022 longlist for the Health Tech World incredible women in health tech – and now the company is up for another prestigious award as a health tech innovator. 

Forth is well-known in health tech and fem tech for addressing health issues faced by women due to the gender health gap and a lack of investment in key areas of female health – particularly hormone health.

Femtech AI success

Their product MyFORM was created to address the shortcomings of current tests which only measure hormones on a single day. It uses blood analysis combined with AI to map four key female hormones across a woman’s entire menstrual cycle – giving much deeper insight into the complex female hormone network.

The development of this product is part of the company’s mission to empower women to become experts on their own body through scientific knowledge and understanding.

Sarah Bolt, Co-Founder of Forth said: “We’re honoured to have been considered for this prestigious award alongside so many amazing entries. It’s a great motivation to know that our work doesn’t go unnoticed as we continue to make women’s health a priority. We’d like to thank everyone involved for our nomination and look forward to the event in November!’’

LaingBuisson Awards 2022

The LaingBuisson Awards are held annually and aim to recognise excellence across several industries. From innovation awards to honouring advisors and clinical services, the ceremony is an extremely prestigious event that has been running for 17 years.

The ceremony and dinner are set to take place on Thursday 17th November, at the Park Plaza Westminster Bridge Hotel in London. 

With so many amazing people and companies considered for awards, the event is set to be an exciting night for several industries.

Advancing women’s hormone health

MyFORM is a groundbreaking test which maps how a woman’s key hormones fluctuate throughout her entire cycle rather than on a single day, which is current clinical practice. 

The finger prick home test uses two samples of blood taken on day 14 and day 21 of a woman’s menstrual cycle. 

The blood samples are analysed to measure the levels of the four key female hormones – follicle stimulating hormone, luteinising hormone, oestradiol, and progesterone.

The 8 data points are combined with Forth’s proprietary AI algorithm to predict how each hormone fluctuates across a woman’s individual cycle length. 

It also provides women with an ovarian responsiveness score (FORM), indicating how well their ovaries are functioning.

Other finalists for ‘innovation in health tech’

  • Air Doctor
  • Birdie
  • C2-Ai
  • Check4Cancer
  • Cyted
  • Medica
  • SilverCloud Health

 

Don’t miss…

Incredible women in health tech | the 2022 longlist

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending stories